NL-OMON21045
Suspended
Not Applicable
Treatment of Complex Regional Pain Syndrome type I; A randomised, single-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions.
eiden University Medical Center (LUMC), Department of Anesthesiology0 sites30 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Complex Regional Pain Syndrome type I (CRPS type I)Complex Regionaal Pijn Syndroom type I (CRPS type I)
- Sponsor
- eiden University Medical Center (LUMC), Department of Anesthesiology
- Enrollment
- 30
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. CRPS type I diagnosis according to the IASP\-criteria;
- •2\. NRS spontaneous pain score of 5 or higher;
Exclusion Criteria
- •1\. Patients who are not able to give informed consent;
- •2\. Patients suffering from other syndromes/diseases interfering with pain ratings;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Treatment of Complex Regional Pain Syndome type 1: a randomised, double-blind, placebo-controlled study with S(+)-ketamine.Complex Regional Pain Syndome type 1 (CRPS 1)NL-OMON22578eiden University Medical Center, dep. Anaesthesiology60
Withdrawn
Phase 4
Treatment of Complex Regional Pain Syndrome type I;A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions (The Ket Ket Study)NL-OMON31841eids Universitair Medisch Centrum30
Active, not recruiting
Not Applicable
Treatment of Complex Regional Pain Syndrome type I: A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions - KetKetStudyChronic CRPS ianEUCTR2008-003693-17-NLeiden University Medical Center30
Active, not recruiting
Not Applicable
A study the safety and effects of ARA 290 administered subcutaneously on pain relief in patients with chronic pain from complex regional pain syndrome type 1.EUCTR2012-003688-24-NLeiden University Medical Center
Withdrawn
Phase 2
Treatment of Complex Regional Pain Syndrome type 1: A randomized placebo controlled double-blind study with ARA 290, The CRPSARA Studynerve painneuropathic pain10034606NL-OMON37009eids Universitair Medisch Centrum40